Claudineia Almeida de Souza1, Raquel Rocha1, Priscila Ribas de Farias Costa2, Naiade Silveira Almeida3, Helma Pinchemel Cotrim4. 1. Universidade Federal da Bahia, Programa de Pós-Graduação em Alimentação, Nutrição e Saúde, Salvador, BA, Brasil. 2. Universidade Federal da Bahia, Escola de Nutrição, Departamento de Ciências da Nutrição, Salvador, BA, Brasil. 3. Universidade Federal da Bahia, Programa de Pós-Graduação em Medicina e Saúde, Salvador, BA, Brasil. 4. Universidade Federal da Bahia, Faculdade de Medicina da Bahia, Salvador, BA, Brasil.
Abstract
BACKGROUND: Supplementation with probiotics, prebiotics and symbiotics has shown positive effects on clinical markers and risk factors for non-alcoholic fatty liver disease (NAFLD). OBJECTIVE: To evaluate the effect of supplementation with probiotic, prebiotic or symbiotic on intestinal microbiota in NAFLD patients. METHODS: Two investigators conducted independently search for articles in the Medline databases, via PubMed, Web of Science, Embase, Scopus, Lilacs, Central Cochrane Library, Clinical Trials.gov and on the Ovid platform for the gray literature search. RESULTS: A total of 3,423 papers were identified by searching the electronic databases; 1,560 of them were duplicate and they were excluded; 1,825 articles were excluded after reading the title and abstract. A total of 39 articles were select to reading, however only four articles met the eligibility criteria to include in this systematic review. Three of the included studies that used prebiotic or symbiotic supplementation showed that after the intervention there were changes in the intestinal microbiota pattern. Only in one study such changes were not observed. A high risk of bias was observed in most assessments. CONCLUSION: Although there is a possible change in the gut microbiota of individuals with NAFLD after supplementation with symbiotics or prebiotics, a clinical indication as part of NAFLD treatment is not yet possible.
BACKGROUND: Supplementation with probiotics, prebiotics and symbiotics has shown positive effects on clinical markers and risk factors for non-alcoholic fatty liver disease (NAFLD). OBJECTIVE: To evaluate the effect of supplementation with probiotic, prebiotic or symbiotic on intestinal microbiota in NAFLD patients. METHODS: Two investigators conducted independently search for articles in the Medline databases, via PubMed, Web of Science, Embase, Scopus, Lilacs, Central Cochrane Library, Clinical Trials.gov and on the Ovid platform for the gray literature search. RESULTS: A total of 3,423 papers were identified by searching the electronic databases; 1,560 of them were duplicate and they were excluded; 1,825 articles were excluded after reading the title and abstract. A total of 39 articles were select to reading, however only four articles met the eligibility criteria to include in this systematic review. Three of the included studies that used prebiotic or symbiotic supplementation showed that after the intervention there were changes in the intestinal microbiota pattern. Only in one study such changes were not observed. A high risk of bias was observed in most assessments. CONCLUSION: Although there is a possible change in the gut microbiota of individuals with NAFLD after supplementation with symbiotics or prebiotics, a clinical indication as part of NAFLD treatment is not yet possible.
Authors: Rodrigo Zamignan Carpi; Sandra M Barbalho; Katia Portero Sloan; Lucas Fornari Laurindo; Heron Fernando Gonzaga; Paulo Cesar Grippa; Tereza L Menegucci Zutin; Raul J S Girio; Cláudia Sampaio Fonseca Repetti; Cláudia Rucco Penteado Detregiachi; Patrícia C Santos Bueno; Eliana de Souza Bastos Mazuqueli Pereira; Ricardo de Alvares Goulart; Jesselina Francisco Dos Santos Haber Journal: Int J Mol Sci Date: 2022-08-08 Impact factor: 6.208